The global autoinjectors market  size is estimated to grow by USD 303.65 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 36.72%  during the ...

Botswana’s Country Cooperation Strategy 2024-2027, in partnership with WHO, presents a strategic plan to tackle the nation's ...

Southeast Asia Olmesartan Market was valued at US$ 335.2 million in 2023 and is projected to surpass a valuation of US$ 518.8 million by 2032 at a CAGR of 4.3% during the forecast period 2024–2032.

Due to the prevalence of both NSAID use and hypertension, even modest elevations in blood pressure or inhibition of antihypertensive medication efficacy resulting from NSAIDs may be of significant ...

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk ...

The global diabetic nephropathy market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the ...

Hypertension is a leading risk factor for cardiovascular disease, the leading cause of death and morbidity in our society and on a global scale ... was suitable. The prevalence of hypertension in the ...

Curatis Holding (SIX:CURN) reports revenues of CHF 2.0m for H1 2024, whereby Curatis AG is only included for 2 months. Curatis AG was able to increase sales in the distribution business by 31% per ...

Maasai leaders have argued that this dependence is enabling the government to justify relocating people, even though the ...